Work

Intravenous administration of a novel IL-2 fusion protein, ALT-801, inhibits bladder cancer in mouse models (46.35)

Year: 2012

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.188.supp.46.35

Authors: Hing Wong, Jinghai Wen, Lijing You, Wenxin Xu, Ana Edwards, Peter Rhode

Institution: Altor BioScience (United States)

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1570263903

Cites:

Cited by: 1

Related to: 10